AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Primary Health Properties PLC

Director's Dealing Mar 6, 2024

4780_dirs_2024-03-06_b12a0ee3-a333-4d16-9dd3-7dd480e0f788.html

Director's Dealing

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 8737F

Primary Health Properties PLC

06 March 2024

Primary Health Properties PLC

Director's & PDMR Dealings - LTIP Vesting

Primary Health Properties PLC (the "Company" or "PHP"), one of the UK's leading investors in modern primary healthcare facilities, announces that Richard Howell, Chief Financial Officer, together with certain other persons discharging managerial responsibility ("PDMRs") and employees have received Ordinary Shares of 12.5 pence each in the Company ("Ordinary Shares") under the terms of the Company's Long-Term Incentive Plan ("LTIP") (the "Vesting").  

The awards vested on 6 March 2024 for nil consideration pursuant to a conditional award made on 12 May 2021.  For Mr Bateman and Mr Austin, the number of Ordinary Shares which vested is stated after the deduction of the relevant taxation and National Insurance charges. No such deduction applies for Mr Howell, by whom relevant taxation and National Insurance charges will be paid separately.

Director Number of shares vesting
Richard Howell 25,081
PDMR
David Bateman 7,144
David Austin 3,072

All Ordinary Shares in connection with the Vesting will be transferred to the relevant individuals from the Company's employee benefit trust ("EBT"), save for those to which Mr Howell is entitled, which will be retained in the EBT for a further two years under deferred payment arrangements relating to him.

Details of the operation of the LTIP are set out in the Company's 2022 Report and Accounts.

Details of the transactions referenced above are included below in accordance with Article 19 of the retained EU law version of the Market Abuse Regulation (Regulation 596/2014).

1 Details of the person discharging managerial responsibilities/persons closely associated
(a) Name Richard Howell
2 Reason for notification
(a) Position/Status Chief Financial Officer
(b) Initial notification/amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
(a) Name Primary Health Properties PLC
(b) LEI 213800Y5CJHXOATK7X11
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date: and (iv) each place where transactions have been conducted
(a) Description of the financial instrument, type of instrument and identification code Ordinary shares of 12.5p

ISIN: GB00BYRJ5J14
(b) Nature of transaction Vesting of conditional share awards under the Company's LTIP
(c) Price(s) and volume(s) Price(s) Volume(s)
Nil cost 25,081
(d) Aggregated Information Single transaction: N/A
(e) Date of transaction 6 March 2024
(f) Place of transaction London Stock Exchange (XLON)
1 Details of the person discharging managerial responsibilities/persons closely associated
(a) Name David Bateman
2 Reason for notification
(a) Position/Status PDMR
(b) Initial notification/amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
(a) Name Primary Health Properties PLC
(b) LEI 213800Y5CJHXOATK7X11
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date: and (iv) each place where transactions have been conducted
(a) Description of the financial instrument, type of instrument and identification code Ordinary shares of 12.5p

ISIN: GB00BYRJ5J14
(b) Nature of transaction Vesting of conditional share awards under the Company's LTIP and transfer of Ordinary Shares to the PDMR
(c) Price(s) and volume(s) Price(s) Volume(s)
Nil cost 7,144
(d) Aggregated Information Single transaction: N/A
(e) Date of transaction 6 March 2024
(f) Place of transaction London Stock Exchange (XLON)
1 Details of the person discharging managerial responsibilities/person closely associated
(a) Name David Austin
2 Reason for notification
(a) Position/Status PDMR
(b) Initial notification/amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
(a) Name Primary Health Properties PLC
(b) LEI 213800Y5CJHXOATK7X11
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date: and (iv) each place where transactions have been conducted
(a) Description of the financial instrument, type of instrument and identification code Ordinary shares of 12.5p

ISIN: GB00BYRJ5J14
(b) Nature of transaction Vesting of conditional share awards under the Company's LTIP and transfer of Ordinary Shares to the PDMR
(c) Price(s) and volume(s) Price(s) Volume(s)
Nil cost 3,072
(d) Aggregated Information Single transaction: N/A
(e) Date of transaction 6 March 2024
(f) Place of transaction London Stock Exchange (XLON)

More information on Primary Health Properties PLC can be found on www.phpgroup.co.uk

Further details for enquiries:

Harry Hyman

Chief Executive Officer

Tel: +44 (0) 7973 344768
Steven Owen

Chairman

Tel: +44 (0) 203 8241 841
Richard Howell

Chief Financial Officer

Tel: +44 (0) 7766 072272
David Rydell / Stephanie Whitmore (Buchanan Communications)

Tel: +44 (0) 20 7466 5066

Legal Entity Identifier: 213800Y5CJHXOATK7X11

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHBSGDXLUGDGSL

Talk to a Data Expert

Have a question? We'll get back to you promptly.